Clinical Trial Update: Lactoferrin Prophylaxis in VLBW and Regulator T-cells [NA]

View source ↗

Summary

An Ankara University trial evaluating lactoferrin prophylaxis in very low birth weight infants for prevention of late-onset neonatal sepsis and necrotizing ente…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-onset Neonatal Sepsis
• Necrotizing Enterocolitis

Drugs mentioned

• Lactoferrin (lactoferrin)

Snippet

Sponsor: Ankara University | Conditions: Late Onset Neonatal Sepsis, Necrotising Enterocolitis | NA | Status: COMPLETED